CGAS and Alzheimer disease: Although no cure exists for AD or other forms of dementia, targeting neuroinflammatory signaling such as modulating microglial activation, inhibiting pro-inflammatory cytokines, or suppressing the cGAS-STING pathway has emerged as a promising therapeutic strategy for their potential to slow disease progression and preserve cognitive function [9,14].